Biotech VC Funds

LDV Capital, founded in 2012 and based in New York, is a venture capital firm specializing in early-stage investments in visual technology and artificial intelligence. The firm focuses on backing deep technical teams across North America and Europe that leverage computer vision, machine learning, and AI to analyze visual data. LDV Capital's investments span various industries, including healthcare, agriculture, manufacturing, and content creation. The firm has a robust network of computer vision experts, serial entrepreneurs, and technical advisors, which it uses to support its portfolio companies. Notable investments include Clarifai, Uizard, Synthesia, and Ezra, reflecting LDV's commitment to innovative visual tech solutions. LDV Capital's founder and General Partner, Evan Nisselson, brings extensive experience as a serial entrepreneur and digital media expert. LDV Capital hosts an annual summit dedicated to visual technologies and maintains a strong community through monthly dinners and networking events, fostering collaboration and innovation within its portfolio and the broader tech ecosystem. The firm recently closed its fourth fund at $31 million, continuing its mission to support groundbreaking visual technology startups.

Leaps by Bayer, founded in 2015, is Bayer AG's strategic impact investment unit focusing on transformative biotechnologies in health and agriculture. Since its inception, Leaps by Bayer has invested over $1.9 billion in more than 60 ventures, targeting significant challenges through ten key "leaps" designed to address pressing global issues. Key investments include Recursion Pharmaceuticals, which focuses on drug discovery using AI, and BlueRock Therapeutics, a company specializing in cell therapy. These investments align with their strategic goals such as curing genetic diseases, developing sustainable organ and tissue replacements, and reducing the environmental impact of agriculture. Leaps by Bayer's portfolio companies operate autonomously, but benefit from Bayer’s active incubation model, which provides resources and strategic guidance. This approach helps them focus on long-term, high-impact results rather than short-term gains. Leaps by Bayer also collaborates globally with partners in industry, academia, and civil society to drive these innovations forward.

Leawood Venture Capital, established in 2016, is an early-stage investment firm based in Leawood, Kansas. The firm is dedicated to backing disruptive technology companies, with a particular focus on sectors such as artificial intelligence, data analytics, cybersecurity, fintech, and edge computing. Leawood's approach is highly strategic, leveraging its team’s deep experience and national network to help portfolio companies scale and succeed. Typically investing between $2 to $4 million, Leawood often leads or co-leads investment rounds in high-potential companies. The firm has made notable investments in businesses like Sorcero, which develops AI solutions for the life sciences industry, and InsightRX, a leader in precision medicine using machine learning and clinical algorithms to optimize patient treatment. Other portfolio highlights include companies in areas like telecommunications, predictive analytics, and AI-driven customer experience platforms. Leawood’s founding partners, Karl Gemperli and Brendan Fallis, bring decades of operational and entrepreneurial expertise. Gemperli, with a background in industrial IoT and wireless technologies, and Fallis, a former executive at Verizon Wireless, offer invaluable experience in scaling technology ventures. Alongside managing director Todd Daniels and a seasoned investment committee, the team provides hands-on support to startups, from business development to financial operations. With a focus on creating long-term value, Leawood Venture Capital continues to be a key player in supporting early-stage tech companies across the U.S., using their industry knowledge and vast networks to drive innovation and growth.

Legend Capital, established in 2001, is a leading venture capital and private equity firm in China. The firm focuses on early-stage and growth-stage investments, managing over $10 billion in commitments. With a strong presence in Beijing, Shanghai, Shenzhen, Hong Kong, Seoul, and Singapore, Legend Capital has invested in around 600 companies across various sectors. Some of their notable investments include Pony.ai, which focuses on autonomous driving technology, and Beijing ESWIN Technology Group, a key player in semiconductor products and services. Legend Capital also supports companies like ZongmuTech in autonomous driving and Atour, a lifestyle accommodation brand. Additionally, they have invested in prominent companies like Bilibili, a leading video community, and Tuhu, an automotive consumer service platform. Legend Capital has a significant footprint in the life sciences sector, with portfolio companies like Recbio, a novel vaccines company, and Pharmaron, a leading contract research organization. Their investments are characterized by a focus on innovative technologies and solutions that drive industry advancements and address critical needs in the market. The firm is committed to providing comprehensive support to its portfolio companies, including governance, business strategy, R&D resources, and financial backing, helping them to scale and achieve long-term success.

Lerer Hippeau is a prominent seed-stage venture capital firm based in New York City. Founded in 2010, it has built a strong reputation for backing early-stage startups with transformative potential. The firm has invested in over 400 companies, including notable successes like Warby Parker, Allbirds, BuzzFeed, Oscar Health, and ClassDojo. Their portfolio spans various sectors, with significant investments in consumer products, enterprise software, healthcare, fintech, and media. Lerer Hippeau's investment strategy focuses on partnering with innovative founders and providing extensive support to help them grow. They typically invest in seed and early-stage rounds but also participate in follow-on investments to support the continued growth of their portfolio companies. The firm is known for its hands-on approach and deep network, which they leverage to help startups scale. Key figures at Lerer Hippeau include managing partners like Ben Lerer, Eric Hippeau, and Graham Brown, who bring a wealth of experience and industry insight. The firm is recognized for fostering a collaborative and founder-friendly culture, making it a preferred choice for many early-stage entrepreneurs looking for more than just capital. Lerer Hippeau’s notable unicorns include SeatGeek, ClassDojo, and Genies, among others. The firm has also seen several successful IPOs, including companies like Allbirds and Warby Parker, further establishing its reputation as a leading early-stage investor. For startups aiming to connect with Lerer Hippeau, it's beneficial to showcase innovative solutions with strong market potential, aligning with the firm’s focus on supporting transformative and high-growth ventures​.

LetsVenture, established in 2013, is a prominent platform in India's private market investment ecosystem, focusing on early-stage startups. The platform has facilitated over 900 investments, raising more than $250 million for startups, and is backed by notable figures like Ratan Tata and Mohandas Pai. LetsVenture supports a wide array of sectors including e-commerce, software, healthcare, and food and beverage. The platform's investment strategy includes seed and series A rounds, with significant investments in companies like Testbook.com, Innov8 Coworking, and Scripbox. LetsVenture operates through various verticals such as LetsVenture Early Stage, which connects investors with disruptive early-stage startups, and LetsVenture Debt, providing loans to startups for growth. They also offer trica equity, a solution for managing equity, cap tables, and ESOPs. LetsVenture has a robust network of over 20,000 investors and 500 family offices and VCs, making it a vital player in the Indian startup ecosystem. The platform also organizes the annual LetsIgnite event, one of India’s largest conclaves for startup investors, fostering connections and growth within the community​.

Level Up Ventures is a mission-driven venture capital firm based in New York that focuses on closing the racial wealth gap by investing in high-growth startups led by Black and Latino founders. Founded in 2021 and backed by Hearst, the firm offers $300,000 in pre-seed or seed funding along with strategic support and services. They concentrate on tech and tech-enabled companies across various sectors, with a clear emphasis on diversity and inclusivity in their portfolio companies. Level Up Ventures aims to help founders scale through access to Hearst's resources, mentorship, and networks. The firm seeks startups that have validated solutions, demonstrated market traction, and are committed to building diverse teams. Some of the notable companies in their portfolio include Options MD, a healthcare SaaS platform for treatment-resistant depression, and Sunthetics, which uses AI to enhance the development of sustainable materials. They avoid investing in biotech, hardware, or capital-intensive projects. By providing more than just capital, Level Up Ventures combines financial investment with operational expertise, making it a key player in promoting underrepresented founders in the tech space.

Lewis & Clark Ventures is an early-stage venture capital firm based in St. Louis, Missouri, specializing in B2B software investments. Founded by former founders and operators, the firm leverages its team's extensive entrepreneurial experience to partner with dynamic founders aiming to build successful companies. They focus on late seed to Series A investments, typically ranging from $2 million to $3 million per initial investment. The firm's portfolio includes innovative companies like Beam Benefits, Benson Hill, and GreenLight Biosciences. Lewis & Clark Ventures is known for its hands-on approach, often taking board seats and providing strategic, technical, and commercial support to help their portfolio companies scale effectively. Their investment strategy targets high-growth opportunities in overlooked geographies, emphasizing the importance of founder vision, team strength, and market potential. The firm values transparency, smart growth, and long-term partnerships, aiming to support founders not just with capital but also with mentorship and access to their extensive networks.

LG Technology Ventures, founded in 2018 and based in Santa Clara, California, is the corporate venture capital arm of LG Group. The firm focuses on investing in early-stage companies across various sectors, including artificial intelligence, information technology, automotive, life sciences, and energy. With over $400 million in managed assets, LG Technology Ventures aims to drive innovation and growth by partnering with promising startups. Their portfolio includes notable investments in companies like H2O.ai, which offers an open-source machine learning platform; The Sandbox, a virtual metaverse game; and Moloco, which provides AI-enabled mobile DSP software. They have also invested in Element Energy, a battery technology company, and Eatron Technologies, specializing in AI for automotive and electric vehicles​​. The team at LG Technology Ventures consists of experienced investors, technologists, and industry experts, led by Dong-Su Kim, Ph.D., who serves as the CEO. The firm is known for its strategic approach, often leading investment rounds and providing substantial support to its portfolio companies to help them scale and succeed globally.​

Libertus Capital is a London-based venture capital firm, founded in 2017 by Pamir Gelenbe. The firm specializes in investing in early-stage ventures and protocols that focus on enhancing freedom, privacy, and trust, particularly within the blockchain, cryptocurrency, and Web3 sectors. With a global investment outlook, Libertus Capital targets companies across North America, Europe, and Asia. The firm has built a diverse portfolio, backing companies like Livepeer, a decentralized video streaming platform; CoinList, a popular token sale platform; and Kraken, a leading cryptocurrency exchange. Other notable investments include infrastructure and software projects such as Sky Mavis, the developer behind Axie Infinity, and POAP, an NFT-based event engagement tool. These investments underscore Libertus Capital's commitment to supporting projects that leverage decentralized technologies to offer more secure and user-centric solutions. Libertus Capital prefers to invest in seed to Series B rounds, with typical ticket sizes ranging from $5 million to $10 million. They take a hands-on approach, offering not just capital but also strategic guidance and industry expertise to help startups scale. The firm is also actively involved in building long-term value, with exit strategies that include IPOs, mergers, and strategic sales, aligning with their focus on sustainable growth within the rapidly evolving tech landscape.

Lifeline Ventures, based in Helsinki, Finland, is a prominent early-stage venture capital firm co-founded by Petteri Koponen and Timo Ahopelto. Lifeline Ventures is sector-agnostic but has a strong emphasis on health, climate tech, hardware, software, and marketplaces. They focus on investing in resilient founders who aim to become industry leaders. The firm has made significant investments in companies such as Wolt, which was acquired by DoorDash, and Supercell, a gaming giant. Other notable investments include Enevo, Dispelix, and Iceye, showcasing their diverse portfolio and commitment to high-impact sectors. They typically lead funding rounds with check sizes ranging from €300K to €3M, supporting startups from pre-seed to Series B stages. Geographically, Lifeline Ventures primarily invests in startups across Finland, but their reach extends to other parts of Europe and the United States. Their strategy emphasizes deep involvement with their portfolio companies, providing not only capital but also strategic guidance and operational support. The Lifeline Ventures team consists of seasoned entrepreneurs and industry experts, leveraging their extensive experience to help founders navigate the complexities of scaling their businesses. Startups looking to engage with Lifeline Ventures should present innovative solutions with strong growth potential, as the firm is keen on backing companies that can make a substantial impact in their respective industries.

Lightspeed Venture Partners is a prominent global venture capital firm that focuses on seed, early, and growth-stage investments across various sectors, including enterprise, fintech, consumer, and healthcare. Established in 2000, Lightspeed has raised significant capital over the years, including $4.2 billion in 2020 across three funds: an $890 million early-stage fund, a $1.83 billion growth fund, and a $1.5 billion opportunity fund. The firm has a robust portfolio with notable investments in companies like Snap, Nutanix, and Zscaler, reflecting its success in backing high-growth tech startups. Lightspeed has also been instrumental in the growth of other leading companies such as Affirm, MuleSoft, and The Honest Company. Their global reach includes offices in the United States, Israel, India, China, Southeast Asia, and Europe, enabling them to support entrepreneurs worldwide. Lightspeed's investment philosophy centers on deep engagement with their portfolio companies, offering not only capital but also strategic guidance and operational support. This hands-on approach helps startups navigate the challenges of scaling and achieving market leadership. Their commitment to building long-term relationships with founders and their focus on creating enduring companies sets them apart in the venture capital landscape.

Life.SREDA is a Singapore-based venture capital firm, established in 2012, that focuses exclusively on fintech investments. It was one of the first non-corporate VC funds to specialize in fintech, making significant strides in shaping the fintech landscape across Asia and globally. The firm has raised two major funds: Life.SREDA I ($40 million) and Life.SREDA II Asia ($100 million), which have enabled investments in over 20 fintech startups. These include well-known names like Simple, Moven, and Fidor, which are recognized for disrupting traditional financial services. Life.SREDA also manages the BB Fund, a blockchain-focused investment vehicle launched in 2016, further expanding its reach into emerging technologies. The fund targets companies involved in blockchain and cryptocurrency, reflecting its commitment to staying at the forefront of financial innovation. The firm's investment strategy focuses on early-stage companies in the fintech space, helping to nurture them through their growth stages and leading to multiple successful exits, such as Allset Technologies and Life Pay. Life.SREDA has built a reputation as a major player in the Asian fintech ecosystem and continues to invest in companies that are transforming financial services through technology.

LifeForce Capital, founded in 2015 and based in San Francisco, specializes in investing in healthcare companies that are advancing care delivery through innovative technologies and new care models. They focus on digital health startups that enable new therapeutic development and efficient care delivery. Some of their notable investments include Notable Labs, which leverages AI for precision oncology, Clover Health, a technology-driven health insurance company, and One Medical, a membership-based primary care platform. LifeForce Capital targets early to late-stage ventures, with a typical investment ranging from seed to Series B. They emphasize a software-first approach, aiming to drive a paradigm shift in healthcare. Their strategy involves supporting companies that offer scalable solutions with significant potential for improving patient outcomes and healthcare efficiency. The firm has a solid track record with successful exits such as Cricket Health and TARA Biosystems. The investment team, led by founder John Noonan, includes experts like Dr. Dora Hughes and Nathaniel Bays, who bring extensive experience in healthcare investment and operations. For entrepreneurs, LifeForce Capital looks for groundbreaking innovations that align with their mission to reshape healthcare. Startups are advised to present clear, impactful solutions that demonstrate potential for significant advancements in care delivery and therapeutic development​.

Lightbank, founded in 2010 by Brad Keywell and Eric Lefkofsky, is a venture capital firm based in Chicago, Illinois. The firm focuses on early-stage investments, typically in pre-seed, seed, and Series A rounds, with initial check sizes ranging from $250,000 to $5 million. Lightbank has built a diverse portfolio across various sectors, including consumer, enterprise, healthcare, fintech, and climate tech. Among Lightbank's most notable investments are Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare; Sprout Social, a social media management and marketing platform that went public in 2019; Udemy, an online learning and teaching marketplace with over 155,000 courses; Fiverr, an online marketplace for freelance services, which also went public; and Ovia Health, a women's health and family health company acquired by Labcorp. Lightbank has made a total of 219 investments and has had 91 exits, demonstrating a strong track record of successful investments and strategic exits. The firm's latest investments include companies like Aropha and Ohana Subleasing Co., continuing their commitment to innovative and high-potential startups.

Lightrock is a global private equity firm that focuses on investing in sustainable businesses led by purpose-driven entrepreneurs. The firm aims to drive systemic change at scale through innovation, aligning its investments with impact themes such as "people," "planet," and "productivity/tech for good." Founded under the umbrella of LGT, Lightrock is committed to creating positive societal and environmental returns alongside financial gains​. Lightrock's diverse portfolio includes over 60 high-growth companies worldwide. Notable investments include Infarm, a rapidly growing urban farming network; PharmEasy, a leading omni-channel healthcare platform in India; and M-Kopa, a pioneer in pay-as-you-go solar energy services for off-grid customers in East Africa​. The firm actively supports its portfolio companies, often taking board positions to guide their dynamic growth and expansion. Headquartered in London, Lightrock operates globally with a team of more than 55 investment professionals across four continents, encompassing extensive experience in impact investing, leadership, and entrepreneurship. The firm is led by CEO Pal Erik Sjatil, the former Managing Partner of McKinsey & Company Europe​.

Lightship Capital is a venture capital firm with a distinct mission to empower and invest in underrepresented entrepreneurs. Based in Cincinnati, Ohio, Lightship specifically targets startups led by BIPOC (Black, Indigenous, and People of Color), women, LGBTQ+ individuals, and people with disabilities. Their investments span across the Midwest and South, purposefully avoiding oversaturated markets like Silicon Valley, New York, and Boston. The fund’s industry focus includes sectors such as Consumer Packaged Goods (CPG), E-commerce, Sustainability, Artificial Intelligence (AI), and Health Tech. Notable investments include companies like Healthy Roots Dolls, Vyrill, and ProovTest, which exemplify their commitment to supporting high-growth, impactful businesses. Lightship typically invests at the pre-seed to Series A stages, with an average check size of around $2 million. They are known for actively leading rounds and bringing in Executives-in-Residence with experience from major corporations like Procter & Gamble and Cincinnati Children’s Hospital to support portfolio companies. The firm is led by General Partners Candice Matthews Brackeen and Brian Brackeen, who bring extensive experience in fund management and technology. Their approach to sourcing deals emphasizes building relationships within underrepresented communities and fostering long-term success through hands-on mentorship and strategic guidance. For startups looking to connect with Lightship, aligning with their mission to drive systemic change in the venture capital landscape is crucial.

Lightspeed Venture Partners, founded in 2000, is a prominent global venture capital firm based in Menlo Park, California. The firm specializes in multi-stage investments, supporting companies from seed to growth stages. Lightspeed's investment focus spans several sectors, including enterprise, consumer, fintech, and healthcare. Some of Lightspeed's notable investments include Snapchat, Affirm, and Rubrik. Snapchat, a popular social media platform, went public in 2017, marking a significant success for the firm. Affirm, a financial technology company, also achieved a successful IPO in 2021. Rubrik, a leader in cloud data management, is another key company in their portfolio that highlights Lightspeed's focus on disruptive technology. Lightspeed Venture Partners has raised substantial funds over the years to support its diverse portfolio. In 2020, the firm raised $4.2 billion across three funds: an early-stage venture fund, a growth fund for later-stage investments, and an opportunity fund for doubling down on successful investments. The firm's philosophy centers on deep commitment and collaboration with founders, providing not just capital but also strategic guidance and support to help build enduring companies. With a global presence and a history of backing innovative companies, Lightspeed continues to be a key player in the venture capital landscape.

Lightspeed Venture Partners is a prominent venture capital firm based in Menlo Park, California. Established in 2000, Lightspeed has a rich history of investing in a wide array of sectors including enterprise, consumer, fintech, and healthcare. The firm is known for its deep commitment to supporting companies from seed stage through growth stage. Lightspeed's portfolio includes several high-profile companies. They were early investors in Snapchat, Nutanix, MuleSoft, and AppDynamics, all of which have become significant players in their respective industries. Other notable investments include Affirm, Nest, and Ripple, demonstrating Lightspeed's diverse investment strategy and success across various markets​​. In 2020, Lightspeed raised $4.2 billion across three funds to continue supporting early-stage ventures and growth-stage companies. Their investment philosophy focuses on building strong, enduring companies with a hands-on approach, helping founders navigate the complexities of scaling their businesses​​. With a global presence, Lightspeed operates in several countries including the United States, Israel, India, and China. Their international portfolio reflects their ability to identify and nurture innovative companies worldwide.

Lightstone Ventures, founded in 2012, is a venture capital firm that focuses on early-stage investments in the life sciences sector. The firm is based in Menlo Park, California, with additional offices in Boston and Dublin. Lightstone Ventures has a strong track record of investing in biopharmaceutical and medical device companies. Notable investments by Lightstone Ventures include companies such as Reprieve Cardiovascular, which focuses on innovative treatments for heart failure, and Carrick Therapeutics, a biopharmaceutical company developing treatments for cancer. Another significant investment is in Catamaran Bio, which is advancing cell therapies for cancer. The firm recently closed its third fund at $375 million, which will be used to support early-stage companies developing high-impact therapeutics and technologies. Lightstone Ventures' investment strategy emphasizes translating novel scientific breakthroughs into clinically and commercially meaningful therapies. This approach has resulted in successful exits, such as Ra Pharmaceuticals and Disarm Therapeutics, highlighting their ability to nurture companies from inception to market success.

LionBird, founded in 2012 and based in Tel Aviv and Chicago, focuses on early-stage investments in digital health companies. The firm targets startups that are leveraging technology to innovate and improve healthcare delivery and outcomes. Their diverse portfolio includes companies such as Ovia Health, a leader in family health solutions; Marqeta, a modern card issuing platform; and Bizzabo, an event management software company. LionBird has achieved notable exits including Ovia Health and Marqeta, which underline their strategic investment approach and successful track record. LionBird recently closed its third fund at $85 million, indicating strong support from institutional investors like the Healthcare of Ontario Pension Plan (HOOPP). This fund is set to invest in 15 to 20 early-stage companies within the digital health sector, reinforcing their commitment to transforming healthcare through technology. The firm is co-founded by Edward Michael JD, Chaim Friedman, and Jonathan Friedman, who bring extensive experience and a strong network to support their portfolio companies. LionBird aims to provide more than just capital, offering strategic guidance and resources to help startups navigate the complexities of the healthcare industry and achieve market fit.

Lionheart Ventures is a venture capital firm based in San Francisco, focused on mitigating civilizational risks through investments in transformative technologies. They primarily target areas like advanced artificial intelligence and frontier mental health technologies. The firm is guided by the belief that addressing these sectors can significantly impact humanity while generating attractive returns for investors. Lionheart Ventures' notable investments include companies like Anthropic, which specializes in developing general AI systems with an emphasis on responsible usage, and Calm, a global health and wellness app aimed at improving mental health through meditation and relaxation tools. Other significant investments are in Beam, a company focused on urban mobility solutions, and Charm Industrial, which works on carbon removal technologies. The firm is led by founders with extensive experience in venture capital and entrepreneurship, ensuring a deep understanding of the challenges and opportunities faced by startups. Their advisory team includes experts in AI safety, psychedelics, and mental health, such as Dr. Joseph Barsuglia and Allison Duettmann, who provide strategic guidance to portfolio companies. For startups looking to engage with Lionheart Ventures, it is essential to align with their mission of developing technologies that can mitigate existential risks and have a meaningful impact on humanity.

Liquid 2 Ventures, founded in 2015 by Joe Montana, Mike Miller, and Michael Ma, is a San Francisco-based venture capital firm specializing in seed-stage investments. The firm focuses on technology startups, aiming to provide early-stage companies with the capital and guidance needed to grow and succeed. Liquid 2 Ventures has made over 400 investments across various sectors, with notable companies including Athelas, Nurx, and Hyperplane AI​​. Liquid 2 Ventures employs a hands-on approach to investing, leveraging the expertise of its founding partners and a strong network of co-investors, including Y Combinator and Soma Capital. The firm's investment strategy centers around identifying innovative technology solutions and supporting them from their earliest stages. Recent investments include companies like Battlesnake, Overjet, and Pry Financials, which showcase their diverse portfolio spanning artificial intelligence, healthcare, and fintech​. For startups seeking to engage with Liquid 2 Ventures, the firm offers substantial support beyond just funding, focusing on building lasting companies through experience, community, and capital. Their commitment to fostering innovation makes them a valuable partner for early-stage technology ventures looking to make a significant impact.

Litani Ventures is a family office established by Peter Rahal, the founder of RXBAR, and is based in Chicago, Illinois, with an additional office in Miami, Florida. Founded in 2018, Litani Ventures focuses on early-stage investments, particularly in consumer products, food tech, and sustainability. The firm leverages Rahal's entrepreneurial background to invest in companies that have the potential to disrupt traditional industries. Litani Ventures operates with a hands-on approach, working closely with founders to provide strategic guidance and operational support. The firm’s investment portfolio includes a variety of innovative companies, such as Cove, a biodegradable materials company, and Zymochem, a biotechnology firm. Litani Ventures has been actively involved in over 66 investments, highlighting its commitment to fostering the growth of promising startups. In addition to direct investments, Litani Ventures is known for its involvement in successful exits, including high-profile companies like Dr. Squatch and Sprout Social. The firm continues to seek new investment opportunities, particularly in areas where it can have a meaningful impact​.

LocalGlobe, founded by Robin and Saul Klein in 1999, is a leading venture capital firm based in London. The firm focuses on seed and early-stage investments, typically investing $0-1 million. LocalGlobe has built a strong reputation for supporting startups from their inception to successful Series A rounds, often within 15 to 18 months. LocalGlobe is known for its hands-on approach, leveraging a network of industry experts and mentors to help portfolio companies navigate early-stage challenges. The firm looks for founders with a strong vision and passion for their industry, prioritizing solutions that address significant real-world problems. This strategy has led to investments in some of the most transformative companies, such as fintech giants, digital banking solutions, and innovative technology firms. Their focus is primarily on the UK market, deploying about 80% of their capital locally. This commitment to nurturing local talent has solidified their position as one of the most influential seed investors in Europe. LocalGlobe's approach and strategic investments have significantly impacted the global startup ecosystem, making them a crucial player in the venture capital landscape.

Longbow Capital is a Canadian private equity firm focused on investing in energy, power, and infrastructure sectors, with a strong emphasis on energy transition technologies. With over $1.5 billion in assets under management, Longbow has a track record of over 150 high-growth investments. They prioritize companies working towards efficient and environmentally responsible energy solutions, including clean energy, waste-to-power innovations, and advanced energy tech. Longbow’s investment strategy centers on both control and strategic minority positions in companies that are ready to scale. Their Energy Transition Fund is specifically geared toward businesses that capitalize on the global shift toward greener energy, such as Clir Renewables (AI-driven renewable energy software) and Arcus Power (predictive analytics for peak electricity costs). The firm tends to back experienced entrepreneurs with a proven customer base and strong product-market fit​. Headquartered in Calgary, Longbow is led by Managing Directors Larry and Tyson Birchall, with a deep bench of energy investment professionals. The firm’s focus on energy transition makes them a key player in the transformation of how energy is produced and consumed globally​.

Longbow Capital is a UK-based venture capital firm that has been investing in the healthcare, life sciences, and well-being sectors since its founding in 2004. Headquartered in Norwich, the firm primarily focuses on unquoted UK companies with strong growth potential. Longbow Capital specializes in identifying investment opportunities that can deliver exceptional returns for its high-net-worth and professional clients. With a proven track record in both early and late-stage investments, Longbow is particularly interested in innovative healthcare technologies and life sciences, as well as companies that align with the growing well-being industry. The firm's portfolio includes standout companies such as Calon Cardio-Technology and Destiny Pharma, which have progressed through clinical trials and even to IPOs, reflecting Longbow’s ability to back transformative ventures. Longbow is also actively involved in fostering partnerships with innovation hubs like the Boots Centre for Innovation, a collaboration aimed at bringing cutting-edge health and well-being products to market. This initiative, based in Swansea, provides a pathway for early-stage companies and inventors to scale their products within established retail networks, ensuring greater market access. A key aspect of Longbow’s investment strategy is its focus on tax-efficient investment vehicles such as the Enterprise Investment Scheme (EIS) and Business Property Relief (BPR). These schemes offer UK investors significant tax relief on their investments, including income tax, capital gains tax, and inheritance tax benefits. This tax-efficient approach, combined with the firm's deep sector expertise, positions Longbow as a leading investor in the UK’s dynamic healthcare and life sciences landscape​.

LongeVC is a venture capital firm specializing in early-stage investments in biotechnology, with a strong focus on longevity and age-related innovations. Based in Lugano, Switzerland, and Latvia, the firm targets breakthrough startups in sectors like biotech, life sciences, and therapeutics that aim to extend human health and longevity. LongeVC typically invests between €0.5 million and €2.3 million in companies across Europe, the U.S., and Israel. The firm is backed by a deep scientific advisory board and meticulously prioritizes scientific due diligence. Their portfolio includes leading biotech startups such as Insilico Medicine, known for AI-driven drug discovery, and Longenesis, which provides tools for collaborative biotech research. LongeVC's mission is to bring life-changing health technologies to market, addressing global challenges like aging and healthcare. Led by partners like Ilya Suharenko and Garri Zmudze, LongeVC offers not only capital but also strategic business development support, helping founders build scalable businesses that can make a global impact.

Longevity Vision Fund (LVF) is a venture capital firm based in New York City, founded by Sergey Young. The fund focuses on investing in technologies and companies that aim to extend healthy human lifespans and address the negative effects of aging. With a $100 million fund, LVF supports innovations in preventive medicine, early detection, medical technologies, artificial intelligence in healthcare, longevity therapies, and regenerative medicine. LVF's mission is to accelerate breakthroughs in longevity and make these advancements more accessible and affordable to the general public. Notable investments include Senda Biosciences, a company dedicated to developing treatments through its proprietary molecular platform. The fund is led by Sergey Young, a prominent figure in the longevity space with over 20 years of investment experience. Other key team members include Avetik Arakelyan, Sourav Sinha, and Kris Verburgh, who bring diverse expertise in healthcare, technology, and finance. LVF targets early-stage investments and partners with innovative companies worldwide, aiming to transform the life sciences and healthcare industries. They emphasize a long-term commitment to improving human health and promoting a healthier, longer life for everyone.

Longitude Capital is a healthcare-focused venture capital firm that invests across biotechnology, medical technology, and health solutions sectors. Established in 2006, the firm seeks out transformative companies that can improve clinical outcomes, enhance quality of life, and drive healthcare efficiencies. They invest across various stages, from startups to growth companies, with a unique focus on areas like oncology, neurodegenerative diseases, aging, and cardiovascular solutions. Longitude's approach is flexible, allowing them to invest in early clinical-stage companies, spin-outs, and even publicly traded firms. The firm is known for its involvement in special situations, including recapitalizations and PIPEs (Private Investment in Public Equity). They have a proven track record with successful IPOs and acquisitions, such as Aimmune Therapeutics, KaNDy Therapeutics, and Axonics Modulation Technologies. With $585 million raised in its latest fund (LVP4), Longitude Capital's strategy remains rooted in long-term value creation, bolstered by robust internal research teams. Their offices are located in Menlo Park, Greenwich, and Boston, and they continue to partner with both emerging and established healthcare innovators.

Longwall Ventures is a UK-based venture capital firm specializing in early-stage investments in the health, resilience, and sustainability sectors. Founded with a mission to support innovative startups, Longwall Ventures has a strong focus on companies that leverage science and engineering to create impactful solutions. Notable investments by Longwall Ventures include Wayland Additive, which develops advanced 3D printing technologies; Lightcast Discovery, a biotechnology firm; and Caristo Diagnostics, which focuses on cardiovascular diagnostics. The firm has also invested in Closed Loop Medicine, a company developing personalized drug and digital therapy combinations, and LettUs Grow, which specializes in vertical farming technology. Longwall Ventures is known for its hands-on approach, providing not only capital but also strategic support to its portfolio companies. With a diverse portfolio of over 40 companies, Longwall Ventures continues to play a crucial role in fostering innovation and supporting the growth of early-stage companies in the UK and beyond.

Longwood Fund, founded in 2010 and based in Boston, Massachusetts, is a venture capital firm specializing in creating and investing in science-based companies that develop novel solutions to address important medical needs. The fund's principals have co-founded 25 companies, serving as CEOs, Chief Business Officers, and lead investors, and have helped advance over 20 products to market. Longwood Fund's portfolio includes several notable companies such as Grail, which focuses on early cancer detection, and TScan Therapeutics, which develops novel T cell therapies for cancer. Other significant investments include Immunitas Therapeutics, a company using single-cell genomics to innovate in immune oncology, and Be Biopharma, which is developing engineered B cells as a new category of cellular medicines. The fund emphasizes a value-add investment approach, actively supporting its portfolio companies in accelerating clinical progress from lab to patient. With a strong track record of successful exits, including Pyxis Oncology and PTC Therapeutics, Longwood Fund continues to play a pivotal role in advancing healthcare innovations.

Lonza is a global leader in the life sciences industry, providing contract development and manufacturing services (CDMO) for the pharmaceutical, biotech, and nutrition sectors. With headquarters in Basel, Switzerland, Lonza operates over 50 sites worldwide, offering end-to-end solutions across biologics, small molecules, cell and gene therapies, and more. In addition to its CDMO services, Lonza is deeply involved in venture capital through strategic partnerships and investments. The company collaborates with venture capital firms like ALSA Ventures and Bioqube Ventures to support emerging biotech startups, focusing on developing innovative therapies. Lonza's role in these partnerships often includes early-stage de-risking, development, and manufacturing services, helping startups navigate the complexities of bringing new treatments to market. Lonza has also launched a venture capital fund with Prolog Ventures to invest in North American health and wellness startups. This fund is part of Lonza's broader strategy to foster innovation in the health sector by supporting companies that align with its mission to improve patient outcomes and address unmet medical needs​.

Look Up Ventures is a Copenhagen-based venture capital firm focused on early-stage investments that address climate emergencies and biodiversity loss. Founded by Tommy Ahlers and Nicolaj Reffstrup, the firm backs pragmatic and systemic solutions in sectors like materials, energy, food and agriculture, transport, and carbon management. Their portfolio includes companies like Sirona Technologies, which develops CO2 capture technology, and Rubi, which creates carbon-negative textiles using synthetic biology. Look Up Ventures typically invests between €1.5 million and €3 million in pre-seed to Series A rounds. The team, consisting of experienced founders and operators, provides not just capital but also strategic support, helping startups with scaling, team building, and impact performance. Recent investments include companies such as Arkeon, which turns CO2 into food ingredients, and Ento Labs, which uses AI to optimize energy consumption. The firm operates primarily across Europe and aims to make meaningful contributions to reversing climate change by supporting scalable, science-based innovations.

Lool Ventures is a Tel Aviv-based early-stage venture capital firm that invests primarily in Israeli startups. Founded in 2012, the firm focuses on seed and pre-seed funding, helping ambitious entrepreneurs build innovative companies that can compete on a global scale. Lool Ventures is sector-agnostic, with investments spanning across areas such as fintech, digital health, SaaS, AI, logistics, and more, demonstrating a commitment to backing technology that transforms industries. The firm is known for its hands-on approach, partnering closely with startups to provide not just capital but also strategic guidance, mentorship, and operational support. Lool Ventures typically leads or co-leads investment rounds, and its involvement often extends from the earliest stages through Series A. The firm’s diverse portfolio includes companies like Bringg, a leading logistics platform; CyberMDX, which focuses on healthcare cybersecurity; and Zencity, a data analytics platform for local governments. Lool Ventures’ team, led by General Partners Avichay Nissenbaum and Yaniv Golan, brings a wealth of entrepreneurial experience, which helps them connect with founders and anticipate the challenges faced during the growth phase. With assets under management totaling around $200 million, Lool Ventures continues to play a significant role in Israel’s startup ecosystem, seeking out visionary founders who are ready to innovate and disrupt traditional markets.

Loup Ventures is a Minneapolis and New York-based venture capital firm focused on frontier technologies, including artificial intelligence (AI), augmented reality (AR), virtual reality (VR), and robotics. Founded in 2017 by Andrew Murphy, Doug Clinton, and Gene Munster, the firm invests primarily in early-stage companies that are at the intersection of these emerging technologies. Loup Ventures is research-driven, leveraging in-depth analysis and insights to guide its investment decisions. Notable investments include Neurable, an AI company advancing brain-computer interfaces, and Skupos, a platform providing data solutions for convenience stores. The firm is known for its focus on high-impact sectors like neurotechnology, and the future of transportation, with its portfolio companies aiming to shape the way humans interact with machines and the digital world. Geographically, Loup Ventures focuses on investments across the U.S., with its team frequently engaging in thought leadership through articles and podcasts on technological trends. Their investment strategy emphasizes deep involvement, supporting founders not only financially but also with insights derived from their rigorous market research. The team, led by Gene Munster, a well-known tech analyst, and Andrew Murphy, brings extensive experience in tech and finance. Loup Ventures prefers a hands-on approach, often leading rounds and staying actively involved in guiding startups to scale. Startups looking to attract their attention should highlight disruptive tech in AI or AR, showcasing robust market research and a clear vision for the future.

Lowercarbon Capital, founded in 2018 by Chris and Crystal Sacca, is a venture capital firm dedicated to combating climate change through investments in innovative technologies. Based in Jackson, Wyoming, the firm focuses on backing companies that reduce CO2 emissions, remove existing carbon from the atmosphere, and develop solutions to mitigate the impacts of climate change. Notable investments include Lilac Solutions, which is revolutionizing lithium extraction; Solugen, which produces chemicals using enzymes instead of oil; Commonwealth Fusion Systems, working on fusion energy; and Mosa Meat, creating lab-grown meat to reduce livestock emissions. Lowercarbon Capital has invested in over 160 companies, aiming to combine hard science with ambitious goals to tackle climate challenges. The firm’s strategy emphasizes both financial returns and environmental impact, supporting startups from the R&D stage to seed funding with checks ranging from $50,000 to $1 million. Their comprehensive approach includes not only capital but also strategic guidance and support for founders through a robust ecosystem of industry experts and fellow entrepreneurs​. Led by a team of experienced investors and scientists, including managing partner Chris Sacca, Lowercarbon Capital is positioned at the forefront of climate tech innovation, making significant strides in various sectors such as energy, agriculture, and industrial materials.

Loyal VC is a global venture fund established in 2018 that operates a startup index fund with over 350 investments across more than 60 countries. The firm is known for its unique gate-stage investment process, which reduces systemic bias and aims to unlock greater returns. This process involves multiple rounds of diligence and quarterly redemptions, offering flexibility to high-net-worth individuals and institutions. Loyal VC collaborates closely with INSEAD, Founder Institute, and a network of over 1,000 advisors. This extensive network supports a diverse portfolio of founders, with more than 30% of the portfolio companies led by women CEOs and nearly 30% based in emerging markets. The firm places a strong emphasis on social impact, with 80% of its investments aligned with one or more of the UN Sustainable Development Goals (SDGs). Notable investments by Loyal VC include Sama, a company that brings transparency and verifiability to cross-border blue-collar recruitment, and TechStyle, a digital marketplace for sustainable material sourcing in the fashion industry. The firm also supports companies like CurieMD, a telemedicine platform for menopause care, and Milestone, a financial literacy app aimed at helping parents raise financially responsible children. Loyal VC’s investment focus spans various sectors, including cleantech, fintech, healthcare, and more, reflecting their commitment to backing innovative solutions across the globe. For more information, you can visit their official website.

Ludlow Ventures, founded in 2009 and based in Detroit, Michigan, is a venture capital firm that takes a unique approach to investing by emphasizing strong personal relationships with entrepreneurs. The firm focuses on early-stage investments, particularly in the technology sector. Ludlow Ventures has built a robust portfolio, with notable companies such as Honey, a browser extension for online shopping deals acquired by PayPal; Wag, a dog-walking service; and Product Hunt, a platform for discovering new products. The firm has made over 160 investments and has achieved 24 exits, showcasing their ability to identify and support high-potential startups. Other significant investments include Headout, an on-demand mobile platform for booking tours and activities, and CoverTree, an insurtech company focused on property insurance. Ludlow Ventures operates with a philosophy of "VC without ego," striving to be collaborative and supportive partners to their portfolio companies. The team, led by Managing Partner Jonathon Triest, prides itself on being deeply involved in the success of the startups they back, providing not just capital but also strategic advice and resources.

Lumen Ventures is a Rome-based early-stage venture capital firm that focuses on investing in technology-driven startups, particularly at the seed stage. Established as the first Simple Investment Company (SiS) in Italy, Lumen Ventures manages a €25 million fund aimed at backing high-potential tech startups across sectors like fintech, insurtech, healthtech, and foodtech. Lumen Ventures differentiates itself by being led by a team of former entrepreneurs and operators, which gives them a practical understanding of the challenges faced by startups. This experience enables them to provide not only financial support but also strategic guidance to help founders scale their businesses both in Italy and across Europe. The firm typically invests between €100,000 and €1.5 million per company and is particularly keen on supporting second-time founders. By leveraging their industry expertise and entrepreneurial background, the Lumen Ventures team is committed to helping startups build sustainable growth pathways.

Lumira Ventures is a prominent venture capital firm specializing in life sciences and healthcare investments. Established in 1989 and headquartered in Toronto, Canada, Lumira Ventures has a robust presence across North America, with offices in Toronto, Montreal, Vancouver, and Boston. The firm focuses on backing innovative biotechnology and medical technology companies that have the potential to address significant unmet medical needs and improve healthcare quality globally. The firm's investment portfolio includes a wide range of companies such as Depomed, Guava Technologies, Think Research, and U-Systems, showcasing their diverse interest in biopharmaceuticals and medical devices. Notable recent investments include Antiva Biosciences, developing topical therapies for HPV-related pre-cancerous lesions, and Arclight Therapeutics, focusing on neurodegenerative diseases. Lumira Ventures' investment strategy involves providing substantial support to their portfolio companies, from early-stage funding to strategic guidance. They recently closed their Lumira Ventures IV fund at $220 million, the largest life sciences venture fund ever raised in Canada, highlighting their significant role in the sector. Overall, Lumira Ventures is dedicated to advancing healthcare innovation through strategic investments and active support of pioneering companies in the life sciences domain.

Lunar Ventures is a Berlin-based venture capital firm focused on investing in deep-tech startups across Europe. The firm specializes in early-stage companies, often leading seed rounds with investments ranging from €300K to €1M. Lunar Ventures primarily targets highly technical founders working on breakthrough innovations in fields like artificial intelligence, cryptography, cloud infrastructure, and advanced computing. Their mission is to support visionary entrepreneurs building cutting-edge technologies that address complex, global challenges. What sets Lunar Ventures apart is their deep technical expertise. The team comprises engineers, computer scientists, and tech-bio specialists who provide hands-on support to portfolio companies. This background enables them to understand and back startups tackling the most complex technical problems, often before they generate revenue. The firm is committed to helping these companies scale, offering both financial capital and strategic guidance throughout their development journey. Lunar’s portfolio reflects its commitment to innovation, featuring companies such as Zama, which focuses on privacy-preserving AI, and Bedrock, which is revolutionizing ocean floor mapping with autonomous underwater vehicles. Lunar’s approach to investing emphasizes a long-term vision, partnering with startups from seed to Series A and beyond, helping them navigate the challenges of growth in the deep-tech ecosystem. Based in Berlin, Lunar Ventures operates across Europe, working with companies that are redefining industries through science and engineering, and making an impact in sectors ranging from AI to biotech and beyond.

Lux Capital is a leading venture capital firm renowned for its investments in groundbreaking science and technology ventures. With a portfolio boasting companies like Recursion Pharmaceuticals, Desktop Metal, and Matterport, Lux Capital focuses on industries such as biotechnology, material science, and artificial intelligence. The firm invests primarily in early-stage startups but is versatile enough to support companies through later stages as well. Lux Capital is geographically centered in the United States, with a strong presence in New York and Silicon Valley. Their investment strategy is defined by backing counter-conventional ideas that push the boundaries of current technology and science. They are known for making substantial investments, often leading funding rounds, and providing robust support to their portfolio companies to ensure their long-term success. The firm is managed by an experienced team including co-founders Peter Hébert, Robert Paull, and Joshua Wolfe. Their approach is hands-on, offering not just capital but also strategic guidance, networking opportunities, and operational support. Lux Capital values innovative pitches and prefers to be approached with well-researched and transformative ideas. In recent years, Lux Capital has been highly active, raising significant funds like the $1.15 billion for its eighth fund. The firm’s commitment to pioneering technologies is evident in their diverse investments, from AI-driven biotech firms like Evolutionary Scale to innovative aerospace companies like Planet.

M Ventures, the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany, was established in 2009. The fund focuses on investments in biotechnology, healthcare, life science tools, electronics, and frontier technologies aimed at sustainability. With a dual focus on strategic and financial returns, M Ventures has a broad investment portfolio that targets transformational ideas and innovative solutions. M Ventures has committed €600 million to support its investments, allowing it to back both early-stage and more advanced companies. The fund has a strong track record with over 115 deals and 86 portfolio startups. Notable investments include companies like Artios Pharma, which focuses on DNA damage response therapies for cancer, and Storm Therapeutics, which specializes in RNA modulation. The venture capital arm takes an active role in its portfolio companies, collaborating closely with entrepreneurs and co-investors to drive innovation and commercial success. M Ventures' strategy includes making early-stage investments and helping companies develop technologies that align with Merck’s long-term R&D goals.

M12, Microsoft's venture fund, focuses on early-stage investments, primarily in Series A and B rounds. Established in 2016, M12 has quickly become a significant player in the venture capital landscape, leveraging Microsoft's extensive network and resources to support its portfolio companies. M12's investment areas include AI, cloud infrastructure, cybersecurity, developer tools, vertical SaaS, and emerging technologies like Web3 and gaming. Notable investments by M12 include companies such as SpaceX, Addepar, GoPuff, BitGo, and Dataminr. Additionally, M12 has backed promising startups like BlueVine in vertical SaaS, Bolster in cybersecurity, and Bonsai in AI. M12 also focuses on fostering innovative solutions in autonomous systems and frontier technologies​. The fund operates with a close alignment to Microsoft, which allows it to provide unique benefits and opportunities for its portfolio companies, such as integrations with Microsoft Azure and other enterprise solutions. This strategic alignment helps startups accelerate their growth and expand their market reach by leveraging Microsoft's extensive ecosystem.

M13 is a venture capital firm based in Santa Monica, California, known for its early-stage investments in disruptive technology and consumer-focused companies. Founded in 2016 by brothers Carter and Courtney Reum, M13 has established a robust portfolio that includes notable companies such as Ring, Cue, Daily Harvest, FabFitFun, ClassPass, Matterport, and Capsule. M13's investment strategy spans several sectors including health, commerce, work, and money, with a strong focus on infrastructure technologies such as AI and web3. The firm leverages its Propulsion Platform, which combines operational expertise and strategic guidance to help startups scale efficiently. This platform ensures that each founder receives tailored support, significantly enhancing their chances of success. M13 has recently launched its third fund, raising $400 million to continue backing early-stage teams. Their approach involves writing checks of up to $15 million from Seed to Series B stages, often leading the investment rounds. This fund aims to capitalize on the evolving consumer behavior and the growing importance of horizontal technology layers, including blockchain-based applications governed through tokens.

M25 is an early-stage venture capital firm based in Chicago, focusing on investments in startups headquartered in the Midwest. Founded in 2015, M25 has quickly become one of the most active seed investors in the region, with over 90 investments across a variety of industries, including AI, fintech, e-commerce, healthcare, and software. Notable investments from M25 include companies like Upsie, a warranty services provider; Avail, a platform for landlords and tenants; and PactSafe, a contract acceptance platform. The firm has a strong focus on supporting innovative and high-growth potential startups, leveraging their extensive network and resources to help these companies scale effectively. M25’s investment strategy involves making initial investments ranging from $500,000 to $1.5 million and often taking board seats to provide strategic guidance. The firm emphasizes a data-driven approach to investment decisions and maintains a hands-on relationship with its portfolio companies to support their growth and success.

Madrona Venture Group, founded in 1995 and based in Seattle, Washington, focuses on early-stage and seed investments, particularly in the Pacific Northwest. The firm is known for its commitment to long-term partnerships with entrepreneurs, supporting them through the entire lifecycle from idea inception to market success. Madrona has a strong presence in sectors such as AI, intelligent applications, cloud computing, and enterprise software​. Madrona's investment philosophy, "Day One for the Long Run," emphasizes sustained engagement and strategic support. This approach has contributed to the success of companies like Smartsheet and Rover. Smartsheet, for example, overcame significant challenges during the 2008 financial crisis with Madrona's support, eventually going public in 2018. The firm has made over 550 investments, including in prominent companies like Snowflake, Redfin, and Apptio. Recent investments include Tektonic AI and Vilya, reflecting Madrona's focus on emerging technologies and innovative startups​. Madrona's team includes experienced professionals like Matt McIlwain and Scott Jacobson, who bring deep industry expertise and a hands-on approach to working with portfolio companies. This strong partnership ethos and strategic guidance have positioned Madrona as a key player in the venture capital landscape.

Magnet Ventures is a San Francisco-based venture capital firm founded in 2016 by Georgia Lu. The firm primarily focuses on early-stage investments across biotechnology, healthcare, artificial intelligence, and other innovative technology sectors. Magnet Ventures has gained recognition for its strategic investments in companies leveraging advanced technology to transform fields such as drug discovery, diagnostics, and robotics. The firm's investment strategy is characterized by close collaboration with founders, offering not just capital but also strategic guidance and operational support. Magnet Ventures has invested in companies like Flux Biosciences, Atom Bioworks, and CloudMinds Robotics, showcasing its interest in high-potential sectors where AI intersects with biotech. The firm has achieved notable exits, including the sale of CloudMinds Robotics, further solidifying its reputation as a valuable partner for tech-driven startups. Magnet Ventures is led by a small but experienced team, including partners based in the U.S. with deep backgrounds in science, technology, and business. The firm continues to expand its portfolio by focusing on companies that are poised to drive future innovations across a range of critical industries, making it a key player in the global tech investment space.

Magnetic Ventures is a Miami Beach-based venture capital firm founded in 2018 by Christine Aylward. The firm specializes in early-stage investments, primarily focusing on companies at the intersection of technology and life sciences. With a strong emphasis on AI, machine learning, and biotech, Magnetic Ventures backs founders who are developing transformative solutions in healthcare. Their investment portfolio includes cutting-edge companies like Deep Genomics, Spotlight Therapeutics, and Paradigm, which are revolutionizing areas like drug discovery, gene editing, and clinical research. Magnetic Ventures typically makes initial investments ranging from $1 million to $6 million, entering at seed or Series A stages. The firm is deeply involved in supporting its portfolio companies throughout their growth, leveraging its extensive experience in healthcare regulation and commercialization. Their geographical focus is North America and Europe, with offices in Miami, Boston, and Research Triangle Park​. This hands-on approach and a mission to advance patient care through technology have made Magnetic Ventures a key player in driving innovation across the healthcare landscape.